CTRI/2014/03/004470Completed未知
Outcome of patients with severe sepsis who received Ulinastatin (U-Tryp) therapy
MedantaThe medicity0 sites134 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 134
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients admitted in ICU were assessed and included if they were 18 yrs old and full fill the criteria of severe sepsis (Sepsis with organ dysfunction or tissue hypoperfusion).
Exclusion Criteria
- •Terminally ill patients
- •Acute Myocardial infarction
- •Hypersensitivity to U-trip
- •Chronic treatment with immuno suppressive drugs
Investigators
Similar Trials
Not yet recruiting
Unknown
A clinical trial to study the prediction of outcome in patients with sepsis using acute phase reactants and SOFA Scoring system.CTRI/2024/06/069560Dr Kajal Magnani
Completed
Phase 2
Pilot randomised controlled trial of continuous beta-lactam infusion compared with intermittent dosing in critically ill patientsACTRN12610000238077Beta-Lactam Infusion Group60
Completed
Not Applicable
A STUDY OF PREDICTORS OF SEVERITY OF INFECTION WITH ITS PROGNOSIS ON TREATMENTCTRI/2019/02/017377Kasturba Hospital96
Not yet recruiting
Not Applicable
Patient admitted in a medical icu and who have infection affecting the whole body are taken into study. Their sequential organ failure assessment score and C-reactive protein is compared to predict outcome.CTRI/2017/08/009268Kasturba Medical College Manipal104
Recruiting
Not Applicable
eurological Sequelae of Sepsis (NeuroSOS-CIP): Investigation of nerve and muscle in patients with critical illness polyneuropathy (CIP) using MRISepsis, unspecifiedA41.9G62.8G72.8G62.80Other specified polyneuropathiesOther specified myopathiesDRKS00000652CSCC Jena (Center for Sepsis Control and Care)Hans Berger Klinik für Neurologie100